The MELD score is calculated using blood test results for three key values: bilirubin, creatinine, and INR (a measure of blood clotting). These numbers are plugged into a logarithmic formula that produces a score ranging from 6 to 40, estimating how urgently a person with liver disease needs a transplant within the next three months. The current version, MELD 3.0, also factors in sodium, albumin, and biological sex.
The Three Core Lab Values
Every version of the MELD score starts with the same three blood tests. Bilirubin measures how well your liver processes waste. When the liver struggles, bilirubin builds up, turning your skin and eyes yellow. Creatinine reflects kidney function, which often declines alongside severe liver disease. INR tells doctors how long your blood takes to clot. A damaged liver produces fewer clotting proteins, so INR rises.
All three values are converted using natural logarithms in the formula, which means small increases in very abnormal lab results have a bigger impact on the score than the same increase would at normal levels. The formula uses bilirubin and creatinine in mg/dL (the standard unit in U.S. labs). If your lab report uses µmol/L, you’ll need to convert before calculating.
The Original MELD Formula
The original MELD calculation multiplies the natural log of each lab value by a specific weight, then adds the results together. Creatinine carries the heaviest weight, followed by bilirubin and INR. Any lab value below 1.0 is rounded up to 1.0 to prevent negative logarithms from pulling the score down artificially. The result is rounded to a whole number.
In practice, almost nobody calculates this by hand. Online calculators from UNOS and major medical centers do it instantly once you enter your lab values. But understanding what goes into the formula helps you see why your score changes when it does. A jump in creatinine, for instance, will move your MELD score more than a comparable change in INR.
How Sodium Changed the Calculation
Low sodium in the blood is an independent predictor of death in liver disease, but the original MELD formula ignored it. The MELD-Na version addressed this by incorporating serum sodium for anyone with an initial MELD score of 12 or higher. Sodium values are capped at a lower limit of 125 and an upper limit of 137, meaning values outside that range don’t push the score further in either direction.
The adjustment works in a specific direction: lower sodium raises your score. A patient with a sodium of 126 and a traditional MELD of 18 could see their score climb several points after the sodium correction. This matters because even a one- or two-point difference can change your position on the transplant waiting list.
MELD 3.0: The Current Version
MELD 3.0 replaced the older versions and added two new variables: serum albumin and biological sex. Albumin is a protein made by the liver, and low levels signal that the liver’s synthetic function is failing. The formula subtracts your albumin from a reference value of 3.5 g/dL, so scores below that threshold push MELD higher.
The sex adjustment adds approximately 1.33 points for female patients. This corrects a documented disparity: women with the same lab values as men had higher 90-day mortality rates under the old system, likely because creatinine runs naturally lower in women and underestimated their kidney dysfunction. Adding the sex coefficient means a female patient receives about one additional MELD point compared to a male patient with identical labs, reflecting a roughly 3-percentage-point increase in predicted 90-day mortality.
MELD 3.0 also introduces interactions between variables. Bilirubin and sodium interact with each other in the formula, as do albumin and creatinine. This means the effect of one abnormal value depends partly on the other. Creatinine is capped at 3.0 mg/dL, so values above that don’t keep inflating the score.
The full MELD 3.0 formula is complex enough that manual calculation isn’t practical. It looks like this: 1.33 × (female sex) + 4.56 × ln(bilirubin) + 0.82 × (137 minus sodium) minus 0.24 × (137 minus sodium) × ln(bilirubin) + 9.09 × ln(INR) + 11.14 × ln(creatinine) + 1.85 × (3.5 minus albumin) minus 1.83 × (3.5 minus albumin) × ln(creatinine) + 6. Use an online calculator.
What the Score Means in Practice
The MELD score estimates your risk of dying within 90 days without a transplant. Higher numbers mean greater urgency, and organs go to the sickest patients first within a given geographic region. The score ranges from 6 (least ill) to 40 (gravely ill) for listing purposes, though the raw calculation can technically exceed 40.
The 90-day mortality risk breaks down roughly like this:
- Below 9: about 1.9%
- 10 to 19: about 6%
- 20 to 29: about 19.6%
- 30 to 39: about 52.6%
- Above 40: about 71.3%
These numbers explain why the jump from the 20s to the 30s feels so significant. A patient at 25 has roughly a one-in-five chance of dying within three months, while a patient at 35 faces coin-flip odds.
Exception Points for Specific Conditions
Some liver conditions are life-threatening but don’t show up in standard lab work. Liver cancer is the most common example. A small tumor may not worsen your bilirubin, creatinine, or INR at all, leaving you with a low MELD score despite having a disease that could progress beyond the point of transplant eligibility.
To address this, the transplant system grants standardized exception points for certain diagnoses. Patients with hepatocellular carcinoma (the most common type of primary liver cancer) qualify for MELD exceptions if their tumors meet specific size criteria: either a single tumor between 2 and 5 cm, or two to three tumors each between 1 and 3 cm. A blood marker called AFP must also be below 1,000 ng/mL. Patients whose tumors start out larger may still qualify through a “downstaging” process, where treatment shrinks the tumors into the eligible range.
These exception points give cancer patients a score that better reflects their true urgency, rather than relying on lab values that may still look relatively normal.
Why Your Score Fluctuates
MELD scores are recalculated regularly using fresh lab draws, and the frequency increases as the score rises. If your score is in the teens, labs might be drawn every few months. In the 30s, they could be drawn weekly. This means your score will bounce around over time, sometimes by several points, based on how your body is doing on that particular day.
Dehydration can temporarily raise creatinine. An infection can worsen bilirubin. Even the timing of a lab draw relative to a meal or medication can introduce small variations. A single score is a snapshot, not a verdict. The trend over time tells a clearer story about whether your liver disease is stable, improving, or progressing.